Titan Pharmaceuticals Inc. (TTNP) recently have taken one step ahead with the beta value of 0.83

Titan Pharmaceuticals Inc. (NASDAQ: TTNP) open the trading on September 10, 2020, with great promise as it jumped 0.25% to $0.20. During the day, the stock rose to $0.2098 and sunk to $0.20 before settling in for the price of $0.20 at the close. Taking a more long-term approach, TTNP posted a 52-week range of $0.14-$0.59.

The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -0.20%. Meanwhile, its Annual Earning per share during the time was 3.20%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 7.90%. This publicly-traded company’s shares outstanding now amounts to $95.66 million, simultaneously with a float of $95.38 million. The organization now has a market capitalization sitting at $21.01 million. At the time of writing, stock’s 50-day Moving Average stood at $0.2764, while the 200-day Moving Average is $0.2615.

It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 21 employees. It has generated 171,952 per worker during the last fiscal year. Meanwhile, its income per employee was -783,714. The stock had 2.55 Receivables turnover and 0.31 Total Asset turnover. For the Profitability, stocks gross margin was +64.33, operating margin was -466.46 and Pretax Margin of -455.77.

Titan Pharmaceuticals Inc. (TTNP) Ownership Facts and Figures

Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Titan Pharmaceuticals Inc.’s current insider ownership accounts for 0.30%, in contrast to 6.10% institutional ownership.

Titan Pharmaceuticals Inc. (TTNP) Earnings and Revenue Records

So, what does the last quarter earnings report of the company that was made public on 6/29/2020 suggests? It has posted -$0.05 earnings per share (EPS) not meeting the forecaster’s viewpoint (set at -$0.03) by -$0.02. This company achieved a net margin of -455.77 while generating a return on equity of -398.31. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.02 per share during the current fiscal year.

Titan Pharmaceuticals Inc.’s EPS increase for this current 12-month fiscal period is 7.90% and is forecasted to reach -0.15 in the upcoming year.

Titan Pharmaceuticals Inc. (NASDAQ: TTNP) Trading Performance Indicators

Let’s observe the current performance indicators for Titan Pharmaceuticals Inc. (TTNP). It’s Quick Ratio in the last reported quarter now stands at 1.60. The Stock has managed to achieve an average true range (ATR) of 0.02. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.38.

In the same vein, TTNP’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.38, a figure that is expected to reach -0.04 in the next quarter, and analysts are predicting that it will be -0.15 at the market close of one year from today.

Technical Analysis of Titan Pharmaceuticals Inc. (TTNP)

[Titan Pharmaceuticals Inc., TTNP] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 42.18% While, its Average True Range was 0.0165.

Raw Stochastic average of Titan Pharmaceuticals Inc. (TTNP) in the period of the previous 100 days is set at 11.16%, which indicates a major fall in contrast to 36.31% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 68.42% that was lower than 112.07% volatility it exhibited in the past 100-days period.

Recent Articles

Callon Petroleum Company (CPE) plunge -3.73% in a week: will this be a lucky break through?

Witnessing the stock’s movement on the chart, on September 22, 2020, Callon Petroleum Company (NYSE: CPE) set off with pace as it heaved 0.56%...

Paramount Group Inc. (PGRE) Open at price of $7.10: A Brand-New Opportunity for Investors

Paramount Group Inc. (NYSE: PGRE) flaunted slowness of -0.99% at $7.01, as the Stock market unbolted on September 22, 2020. During the day, the...

Titan Pharmaceuticals Inc. (TTNP) Moves -0.64% Lower: These Numbers are Too Good to be True

As on September 22, 2020, Titan Pharmaceuticals Inc. (NASDAQ: TTNP) started slowly as it slid -0.64% to $0.20. During the day, the stock rose...

Fulton Financial Corporation (FULT) is set for another landmark as it hit the volume of 1.07 million

Fulton Financial Corporation (NASDAQ: FULT) started the day on September 22, 2020, with a price decrease of -0.76% at $9.14. During the day, the...

Morgan Stanley (MS) last month performance of -6.79% certainly makes it a sizzling prospect

Morgan Stanley (NYSE: MS) open the trading on September 22, 2020, with a bit cautious approach as it glided -1.51% to $47.63. During the...

Related Stories

Leave A Reply

Please enter your comment!
Please enter your name here